News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
70,830 Results
Type
Article (1542)
Company Profile (11)
Press Release (69277)
Section
Business (31366)
Career Advice (54)
Deals (4627)
Drug Delivery (2)
Drug Development (7818)
Employer Resources (9)
FDA (1257)
Job Trends (1696)
News (43321)
Policy (2355)
Tag
Academia (151)
Adcomms (1)
Allergies (11)
Alliances (2451)
ALS (7)
Alzheimer's disease (134)
Antibody-drug conjugate (ADC) (12)
Approvals (1309)
Artificial intelligence (17)
Autoimmune disease (4)
Automation (2)
Bankruptcy (12)
Best Places to Work (1622)
BIOSECURE Act (1)
Biosimilars (2)
Biotechnology (12)
Bladder cancer (16)
Brain cancer (2)
Breast cancer (50)
Cancer (453)
Cardiovascular disease (25)
Career advice (49)
Career pathing (1)
CAR-T (15)
Cell therapy (46)
Cervical cancer (3)
Clinical research (7174)
Collaboration (62)
Compensation (51)
Complete response letters (2)
COVID-19 (179)
CRISPR (4)
C-suite (10)
Cystic fibrosis (18)
Data (588)
Depression (10)
Diabetes (34)
Diagnostics (747)
Digital health (2)
Diversity, equity & inclusion (2)
Drug discovery (8)
Drug pricing (4)
Duchenne muscular dystrophy (34)
Earnings (28578)
Employer branding (1)
Employer resources (7)
Events (8349)
Executive appointments (22)
FDA (1664)
Frontotemporal dementia (2)
Funding (63)
Gene editing (11)
Generative AI (1)
Gene therapy (30)
GLP-1 (68)
Government (204)
Guidances (236)
Healthcare (2102)
HIV (5)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (17)
Immuno-oncology (1)
Indications (10)
Infectious disease (195)
Inflammatory bowel disease (15)
Influenza (9)
Intellectual property (3)
Interviews (3)
IPO (3458)
IRA (2)
Job creations (176)
Job search strategy (46)
Kidney cancer (3)
Labor market (6)
Layoffs (19)
Leadership (1)
Legal (516)
Liver cancer (3)
Lung cancer (94)
Lymphoma (46)
Management (3)
Manufacturing (18)
MASH (18)
Medical device (1761)
Medtech (1763)
Mergers & acquisitions (1250)
Metabolic disorders (100)
Multiple sclerosis (14)
NASH (2)
Neurodegenerative disease (5)
Neuropsychiatric disorders (3)
Neuroscience (215)
NextGen: Class of 2025 (454)
Non-profit (266)
Obesity (47)
Opinion (6)
Ovarian cancer (13)
Pain (7)
Pancreatic cancer (8)
Parkinson's disease (15)
Partnered (1)
Patents (12)
Patient recruitment (13)
Peanut (7)
People (2268)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase I (1732)
Phase II (3058)
Phase III (2941)
Pipeline (946)
Policy (5)
Postmarket research (237)
Preclinical (545)
Prostate cancer (29)
Psychedelics (3)
Radiopharmaceuticals (28)
Rare diseases (51)
Real estate (217)
Recruiting (3)
Regulatory (1865)
Reports (9)
Research institute (143)
Resumes & cover letters (4)
Rett syndrome (2)
RSV (5)
Schizophrenia (24)
Series A (6)
Series B (4)
Service/supplier (1)
Sickle cell disease (8)
Special edition (3)
Spinal muscular atrophy (18)
Sponsored (2)
Startups (113)
State (1)
Stomach cancer (1)
Tariffs (1)
Vaccines (50)
Weight loss (14)
Women's health (3)
Worklife (1)
Date
Today (9)
Last 7 days (41)
Last 30 days (176)
Last 365 days (4480)
2025 (3123)
2024 (4868)
2023 (5331)
2022 (7552)
2021 (6430)
2020 (6114)
2019 (5152)
2018 (3742)
2017 (3562)
2016 (2558)
2015 (3516)
2014 (2237)
2013 (1630)
2012 (1701)
2011 (1897)
2010 (1779)
Location
Africa (52)
Alabama (5)
Alaska (1)
Arizona (17)
Arkansas (1)
Asia (3709)
Australia (434)
California (1236)
Canada (316)
China (89)
Colorado (84)
Connecticut (88)
Delaware (50)
Europe (10796)
Florida (218)
Georgia (32)
Idaho (5)
Illinois (74)
India (6)
Indiana (58)
Iowa (1)
Japan (26)
Kansas (11)
Kentucky (2)
Louisiana (7)
Maine (8)
Maryland (133)
Massachusetts (801)
Michigan (58)
Minnesota (73)
Mississippi (1)
Missouri (10)
Montana (3)
Nevada (14)
New Hampshire (9)
New Jersey (398)
New Mexico (5)
New York (345)
North Carolina (119)
North Dakota (2)
Northern California (647)
Ohio (27)
Oklahoma (1)
Oregon (1)
Pennsylvania (261)
Rhode Island (1)
South America (82)
South Carolina (1)
Southern California (445)
Tennessee (9)
Texas (146)
United States (4398)
Utah (48)
Virginia (12)
Washington D.C. (4)
Washington State (129)
West Virginia (1)
Wisconsin (9)
70,830 Results for "71".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Humanetics Corporation to Present at Radiation Research Society 71st Annual International Meeting
September 10, 2025
·
1 min read
Psychedelics
Cybin’s Small Depression Study Shows 71% Remission Rate
Phase II results for Cybin’s psilocin therapy showed remission rates of 71%, but just eight patients made it to the 12-month milestone.
November 18, 2024
·
2 min read
·
Annalee Armstrong
Press Releases
Non-Small Cell Lung Cancer Therapeutics Market Eyes $71.2 Billion Milestone by 2034
June 17, 2025
·
1 min read
Press Releases
Biotechnology Market Size Expected to Surpass USD 5.71 Trillion by 2034: Biologics, Regenerative Therapies, Chromatography and Tissue Engineering in Focus
July 15, 2025
·
1 min read
Press Releases
Global Telmisartan Market to Surpass USD 5.71 Bn by 2032
April 14, 2025
·
1 min read
Press Releases
Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia
May 2, 2025
·
5 min read
Inflammatory bowel disease
Roche Makes Preclinical IBD Play in $420M+ OMass Pact
The OMass partnership will boost Roche’s strategy in inflammatory bowel diseases, currently led by afimkibart, an anti-TL1A therapy the pharma obtained from its $7.1 billion acquisition of Telavant in 2023.
September 2, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Automated Microbiology Market Size to Reach USD 21.71 Billion By 2034
February 28, 2025
·
1 min read
Press Releases
Lung Cancer Therapeutics Market Size to Reach USD 71.30 Bn by 2034
February 26, 2025
·
1 min read
Press Releases
Breast Cancer Diagnostics Market Size to Attain USD 40.71 Billion by 2034
February 26, 2025
·
1 min read
1 of 7,083
Next
